This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by ROSENBAUM, M. Articles by GERTNER, J. M. Search for Related Content PubMed Articles by ROSENBAUM, M. Articles by GERTNER, J. M.

Metabolic Clearance Rates of Synthetic Human Growth Hormone in Children, Adult Women, and Adult Men^*

Division of Pediatric Endocrinology, New York Hospital-Cornell Medical Center New York New York 10021

Address all correspondence and requests for reprints to: Michael Rosenbaum, M.D., Division of Pediatric Endocrinology, New York Hospital-Cornell Medical Center, 525 East 68th Street, New York, New York 10021.

The MCR of biosynthetic human GH was studied in 12 prepubertal children, 9 adult women, and 13 adult men. Subjects received a constant infusion of biosynthetic GH, and clearance was calculated by dividing the infusion rates by steady state serum concentrations of GH. We found that adult men have a significantly more rapid MCR of human GH than women (125.2 ± 7.6 mL/min-m2 in men; 89.4 ± 7.7 mL/min·m² in women) and that both men and women have a significantly more rapid MCR of human GH than prepubertal children (66.8 ± 7.7 mL/min·m²). Sex differences in GH clearance rates may account at least in part for the lower mean serum GH concentrations in pubertal, but not prepubertal, males compared to those in females. The differences in clearance between prepubertal children and adult women and men suggest that the male-female differences in GH clearance are due to androgen effects on GH clearance or on the relative proportions of free and proteinbound GH in serum. (J Clin Endocrinol Metab 69: 821, 1989)

^* This work was supported in part by Award RR-47 from the General Clinical Research Centers Program of the Division of Research Resources, NIH, and the S. Z. Levine Fellowship Fund.

Received December 1, 1988.

This article has been cited by other articles:

				A. Giustina and J. D. Veldhuis Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human Endocr. Rev., December 1, 1998; 19(6): 717 - 797. [Abstract] [Full Text]

				M. H. MacGillivray, S. L. Blethen, J. G. Buchlis, R. R. Clopper, D. E. Sandberg, and T. A. Conboy Current Dosing of Growth Hormone in Children With Growth Hormone Deficiency: How Physiologic? Pediatrics, August 1, 1998; 102(2): 527 - 530. [Abstract] [Full Text]

				S. A. Chalew, M. Phillip, and A. A. Kowarski Plasma Integrated Concentration of Growth Hormone After Recombinant Human Growth Hormone Injection: Implications for Determining an Optimal Dose Arch Pediatr Adolesc Med, March 1, 1993; 147(3): 274 - 278. [Abstract] [PDF]